Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale-Reference-Cited by-同舟云学术

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

Published:2010-03 Issue:3 Volume:159 Page:331-339
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Lopes Renato D.,Alexander John H.,Al-Khatib Sana M.,Ansell Jack,Diaz Raphael,Easton J. Donald,Gersh Bernard J.,Granger Christopher B.,Hanna Michael,Horowitz John,Hylek Elaine M.,McMurray John J.V.,Verheugt Freek W.A.,Wallentin Lars

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention;Wattigney;Circulation,2003

2. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence;Miyasaka;Circulation,2006

3. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

4. Probability of stroke: a risk profile from the Framingham Study;Wolf;Stroke,1991

5. Present treatment options for atrial fibrillation;Lairikyengbam;Postgrad Med J,2003

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design;American Heart Journal;2024-11

2. Crosslink between atrial fibrillation and cancer: a therapeutic conundrum;Cardio-Oncology;2024-08-07

3. A Common Data Model for Oral Anticoagulants-related Risk of Spontaneous Intracranial Hemorrhage (Preprint);2024-05-01

4. Early versus Later Anticoagulation in Post-Stroke patients with Atrial Fibrillation: A systematic review and Meta-analysis;2024-04-22

5. The Impacts of Oral Anticoagulants on Clinical Outcomes in Patients with Atrial Fibrillation Across Five Stages of Renal Function;2024-04-16